Printer Friendly Version View printer-friendly version
<< Back
Gilead Sciences Announces Fourth Quarter 2018 Dividend
Download PDF Download PDF

FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 25, 2018-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the fourth quarter of 2018. The dividend is payable on December 28, 2018, to stockholders of record at the close of business on December 14, 2018. Future dividends will be subject to Board approval.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Investors
Robin Washington, 650-522-5688
or
Sung Lee, 650-524-7792

NASDAQ (US Dollar)
$69.20
 Stock is Down 0.58 (0.83%)
Data as of 11/16/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Third Quarter 2018 Gilead Sciences Earnings Conference Call

October 25, 2018 4:30 p.m. ET
Play
Gilead Sciences at the Morgan Stanley 16th Annual Global Healthcare Conference

September 12, 2018 11:05 a.m. ET
Play
Second Quarter 2018 Gilead Sciences Earnings Conference Call

July 25, 2018 2:00 p.m. PT
Play
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play